240 related articles for article (PubMed ID: 12707855)
1. Measles infection of the central nervous system.
Schneider-Schaulies J; Meulen Vt; Schneider-Schaulies S
J Neurovirol; 2003 Apr; 9(2):247-52. PubMed ID: 12707855
[TBL] [Abstract][Full Text] [Related]
2. Measles virus infection of the CNS: human disease, animal models, and approaches to therapy.
Reuter D; Schneider-Schaulies J
Med Microbiol Immunol; 2010 Aug; 199(3):261-71. PubMed ID: 20390298
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic aspects of measles virus infections.
Schneider-Schaulies S; ter Meulen V
Arch Virol Suppl; 1999; 15():139-58. PubMed ID: 10470275
[TBL] [Abstract][Full Text] [Related]
4. Measles virus interactions with cellular receptors: consequences for viral pathogenesis.
Schneider-Schaulies J; ter Meulen V; Schneider-Schaulies S
J Neurovirol; 2001 Oct; 7(5):391-9. PubMed ID: 11582511
[TBL] [Abstract][Full Text] [Related]
5. Cell-to-Cell Measles Virus Spread between Human Neurons Is Dependent on Hemagglutinin and Hyperfusogenic Fusion Protein.
Sato Y; Watanabe S; Fukuda Y; Hashiguchi T; Yanagi Y; Ohno S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298883
[TBL] [Abstract][Full Text] [Related]
6. Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis.
Shingai M; Ayata M; Ishida H; Matsunaga I; Katayama Y; Seya T; Tatsuo H; Yanagi Y; Ogura H
J Gen Virol; 2003 Aug; 84(Pt 8):2133-2143. PubMed ID: 12867645
[TBL] [Abstract][Full Text] [Related]
7. Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology.
Watanabe S; Ohno S; Shirogane Y; Suzuki SO; Koga R; Yanagi Y
J Virol; 2015 Mar; 89(5):2710-7. PubMed ID: 25520515
[TBL] [Abstract][Full Text] [Related]
8. Productive measles virus brain infection and apoptosis in CD46 transgenic mice.
Evlashev A; Moyse E; Valentin H; Azocar O; Trescol-Biémont MC; Marie JC; Rabourdin-Combe C; Horvat B
J Virol; 2000 Feb; 74(3):1373-82. PubMed ID: 10627548
[TBL] [Abstract][Full Text] [Related]
9. Measles Encephalitis: Towards New Therapeutics.
Ferren M; Horvat B; Mathieu C
Viruses; 2019 Nov; 11(11):. PubMed ID: 31684034
[TBL] [Abstract][Full Text] [Related]
10. High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice.
Sellin CI; Davoust N; Guillaume V; Baas D; Belin MF; Buckland R; Wild TF; Horvat B
J Virol; 2006 Jul; 80(13):6420-9. PubMed ID: 16775330
[TBL] [Abstract][Full Text] [Related]
11. Pathogenetic aspects of measles virus infections.
Schneider-Schaulies J; Dunster LM; Schneider-Schaulies S; ter Meulen V
Vet Microbiol; 1995 May; 44(2-4):113-25. PubMed ID: 8588304
[TBL] [Abstract][Full Text] [Related]
12. Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.
Mathieu C; Ferren M; Jurgens E; Dumont C; Rybkina K; Harder O; Stelitano D; Madeddu S; Sanna G; Schwartz D; Biswas S; Hardie D; Hashiguchi T; Moscona A; Horvat B; Niewiesk S; Porotto M
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728259
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
14. Modeling subacute sclerosing panencephalitis in a transgenic mouse system: uncoding pathogenesis of disease and illuminating components of immune control.
Oldstone MB
Curr Top Microbiol Immunol; 2009; 330():31-54. PubMed ID: 19203103
[TBL] [Abstract][Full Text] [Related]
15. SLAM- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes.
Alves L; Khosravi M; Avila M; Ader-Ebert N; Bringolf F; Zurbriggen A; Vandevelde M; Plattet P
J Virol; 2015 May; 89(10):5724-33. PubMed ID: 25787275
[TBL] [Abstract][Full Text] [Related]
16. Measles virus and associated central nervous system sequelae.
Buchanan R; Bonthius DJ
Semin Pediatr Neurol; 2012 Sep; 19(3):107-14. PubMed ID: 22889539
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of persistent brain infection with recombinant Measles virus.
Schubert S; Möller-Ehrlich K; Singethan K; Wiese S; Duprex WP; Rima BK; Niewiesk S; Schneider-Schaulies J
J Gen Virol; 2006 Jul; 87(Pt 7):2011-2019. PubMed ID: 16760404
[TBL] [Abstract][Full Text] [Related]
18. Measles virus: cellular receptors, tropism and pathogenesis.
Yanagi Y; Takeda M; Ohno S
J Gen Virol; 2006 Oct; 87(Pt 10):2767-2779. PubMed ID: 16963735
[TBL] [Abstract][Full Text] [Related]
19. Systemic spread of measles virus: overcoming the epithelial and endothelial barriers.
Ludlow M; Allen I; Schneider-Schaulies J
Thromb Haemost; 2009 Dec; 102(6):1050-6. PubMed ID: 19967134
[TBL] [Abstract][Full Text] [Related]
20. Virological and immunological studies in experimental SSPE.
Johnson KP; Byington DP; Gaddis L
Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):495-507. PubMed ID: 616550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
